Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,382 public trials 2,843 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

NCT06333262

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • New England Cancer Specialists Scarborough, Maine, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

V-IMMUNE® for Immune Thrombocytopenia

NCT06962631

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • IMIP Instituto de Medicina Integral Professor Fernando Figueira Recife, Pernambuco, Brazil
  • Santa Casa de Misericórida de São Paulo São Paulo, Brazil
View Trial Details
Recruiting

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

NCT05366881

Conditions
Adnexal Diseases, Bladder Cancer, Blood Protein Disorders, +96 more
Locations
  • City of Hope Duarte, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • North Georgia Health System Gainesville, Georgia, United States
  • Baptist Floyd New Albany, Indiana, United States
View all 17 locations
View Trial Details
Recruiting

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

NCT05512390

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +21 more
Locations
  • University of Arizona Cancer Center - Tucson /ID# 247752 Tucson, Arizona, United States
  • Sylvester Comprehensive Cancer Center - University of Miami /ID# 247232 Miami, Florida, United States
  • Allina Health System /ID# 251782 Minneapolis, Minnesota, United States
  • University of Nebraska Medical Center /ID# 246715 Omaha, Nebraska, United States
View all 20 locations
View Trial Details
Recruiting

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

NCT05143996

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • University of Alabama O'Neal Cancer Center Birmingham, Alabama, United States
  • UCLA Los Angeles, California, United States
  • University of Miami Health System Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions